Cytoo, Cenix BioScience GmbH and Academic Collaborators Bioquant, EPFL and FTMC Receive a 4 Million€ EU FP7 Grant to Launch MEHTRICS Consortium
12/12/2011 8:40:57 AM
More...
|
Cenix BioScience GmbH Signs RNAi Research Agreement with SYGNIS Pharma AG
11/17/2011 12:12:45 PM
More...
|
Cenix BioScience GmbH Grows, Establishing New R&D Subsidiary in Flanders, Belgium
1/12/2011 6:37:09 AM
More...
|
Cenix BioScience GmbH Expands Relationship with AstraZeneca AB, Signing Multi-Project Research Agreement
6/15/2009 8:56:29 AM
More...
|
Cenix BioScience GmbH Follows up Successful RNAi-Based Target Discovery Screens with Target Validation Study for AstraZeneca PLC (AZN)
3/19/2009 9:33:55 AM
More...
|
Cenix BioScience GmbH Signs Research Agreement with Boehringer Ingelheim Corporation for RNAi-Based Target Discovery
2/2/2009 6:15:38 AM
More...
|
InteRNA Technologies and Cenix BioScience GmbH Ink Research Agreement for miRNA Drug Discovery
11/17/2008 10:55:33 AM
More...
|
Instituto de Medicina Molecular, Cenix BioScience GmbH, and Alnylam Pharmaceuticals (ALNY) Discover New Targets in Malaria Infection with RNAi Technology
11/11/2008 9:41:21 AM
More...
|
New Pathway For Malaria Infection Discovered by Cenix BioScience GmbH, Alnylam Pharmaceuticals (ALNY) and Instituto de Medicina Molecular Researchers
9/15/2008 7:50:40 AM
More...
|
Instituto de Medicina Molecular, Cenix BioScience GmbH, and Alnylam Pharmaceuticals (ALNY) Discover New Pathway for Malaria Infection
9/11/2008 8:38:41 AM
More...
|
|